Crossmark

Use of Anti-EGFR Aptamer Construct GR20hh for Controlled Delivery of Doxorubicin into Patient-Derived Glioblastoma Cells

Published Online: 2024-08-13

Published Print: 2024-07

Authors

Ivanov, B. M.

Antipova, O. M.

Sliman, Ya. A.

Samoylenkova, N. S.

Pronin, I. N.

Pavlova, G. V.

Kopylov, A. M.
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-01
More Information

Article History

Received: 5 October 2023

Accepted: 1 December 2023

First Online: 13 August 2024

Document is current